These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 1716671)

  • 1. Acute effects of human recombinant tumor necrosis factor-alpha on the cerebral vasculature of the rat in both normal brain and in an experimental glioma model.
    Kido G; Wright JL; Merchant RE
    J Neurooncol; 1991 Apr; 10(2):95-109. PubMed ID: 1716671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an intratumoral injection of human recombinant tumor necrosis factor-alpha on cerebrovascular permeability and leukocytic infiltration in a rat glioma model.
    Wright JL; Merchant RE
    Acta Neuropathol; 1997 Jan; 93(1):78-86. PubMed ID: 9006660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-alpha in the rat.
    Wright JL; Merchant RE
    J Neurooncol; 1994; 20(1):17-25. PubMed ID: 7807180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological effects of intracerebral injections of human recombinant tumor necrosis factor-alpha in the rat.
    Wright JL; Merchant RE
    Acta Neuropathol; 1992; 85(1):93-100. PubMed ID: 1285500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrovascular effects and tumor kinetics after a single intratumoral injection of human recombinant interleukin-2 alone or in combination with intravenous chemotherapy in a rat model of glioma.
    Watts RG; Merchant RE
    Neurosurgery; 1992 Jul; 31(1):89-98; discussion 98-9. PubMed ID: 1641114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity.
    Havell EA; Fiers W; North RJ
    J Exp Med; 1988 Mar; 167(3):1067-85. PubMed ID: 3351434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antitumor effect of intra-arterial tumor necrosis factor-alpha in rats with transplanted intracerebral glioma and its evaluation by MRI].
    Harada K; Yoshida J; Wakabayashi T; Sugita K; Kurisu K; Uozumi T; Zieroth BF; Takahashi M; Yamanaka T
    No Shinkei Geka; 1995 Dec; 23(12):1069-74. PubMed ID: 8927213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-arterial administration of TNF-alpha followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma.
    Badgwell BD; Valentino DJ; Jeffes EB; Dieffenbach K; Dulkanchainun SB; Yamamoto RS; Granger GA; Jakowatz JG; Carson WE
    Cancer Immunol Immunother; 2003 Jan; 52(1):10-6. PubMed ID: 12536235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of human recombinant tumor necrosis factor on glioma-derived cell lines: cellular proliferation, cytotoxicity, morphological and radioreceptor studies.
    Rutka JT; Giblin JR; Berens ME; Bar-Shiva E; Tokuda K; McCulloch JR; Rosenblum ML; Eessalu TE; Aggarwal BB; Bodell WJ
    Int J Cancer; 1988 Apr; 41(4):573-82. PubMed ID: 2833452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo effects of human recombinant tumor necrosis factor alone and in combination with other biological response modifiers on human digestive organ cancer xenografts transplanted in nude mice.
    Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Masai Y; Tun T; Fukumoto M; Tobe T
    Biotherapy; 1991; 3(4):337-44. PubMed ID: 1786197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracarotid recombinant human tumor necrosis factor-alpha reduces cerebral blood flow and methionine uptake in rat brain tumors.
    Sasajima T; Mineura K; Kowada M; Hatazawa J; Miura S
    J Neurooncol; 1997 Sep; 34(2):123-9. PubMed ID: 9210058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intracarotid and intravenous infusion of human TNF and LT on established intracerebral rat gliomas.
    Liu SK; Jakowatz JG; Pollack RB; Ceraldi C; Yamamoto R; Dett C; Lopez F; Camacho C; Carson WE; Sentovich SM
    Lymphokine Cytokine Res; 1991 Jun; 10(3):189-94. PubMed ID: 1883913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of a novel chimera tumor necrosis factor (TNF-STH) constructed by connecting rTNF-S with thymosin beta 4 against murine syngeneic tumors.
    Noguchi K; Inagawa H; Tsuji Y; Morikawa A; Mizuno D; Soma G
    J Immunother (1991); 1991 Apr; 10(2):105-11. PubMed ID: 2043590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of systemic administration of novel recombinant tumor necrosis factor (rTNF-S) with less toxicity than conventional rTNF-alpha in vivo.
    Gatanaga T; Noguchi K; Tanabe Y; Inagawa H; Soma G; Mizuno D
    J Biol Response Mod; 1989 Jun; 8(3):278-86. PubMed ID: 2746298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic treatment with murine recombinant interleukin-1 beta inhibits the growth and progression of malignant glioma in the rat.
    Rice CD; Merchant RE
    J Neurooncol; 1992 May; 13(1):43-55. PubMed ID: 1613537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effect of recombinant tumor necrosis factor-alpha against murine sarcomas at visceral sites: tumor size influences the response to therapy.
    Mulé JJ; Asher A; McIntosh J; Lafreniere R; Shiloni E; Lefor A; Reichert CM; Rosenberg SA
    Cancer Immunol Immunother; 1988; 26(3):202-8. PubMed ID: 3383204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of recombinant human tumor necrosis factor on rodent gliomas and normal brain.
    Kiwit JC; Schmitz KH; Daum L; Reifenberger G; Roosen N
    J Neurosurg; 1991 Oct; 75(4):597-603. PubMed ID: 1653310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
    Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
    Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged survival of tumor-bearing rats with repetitive low-dose recombinant tumor necrosis factor.
    Sheppard BC; Venzon D; Fraker DL; Langstein HN; Jensen JC; Norton JA
    Cancer Res; 1990 Jul; 50(13):3928-33. PubMed ID: 2354441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice.
    McIntosh JK; Mulé JJ; Travis WD; Rosenberg SA
    Cancer Res; 1990 Apr; 50(8):2463-9. PubMed ID: 2317830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.